The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis

Clinical Nephrology

Volumn 63, Issue 3, 2005, Pages 173-180

  Mackinnon, B ^a   Deighan, C J ^a   Norrie, J ^a   Boulton Jones, J M ^a   Sattar, N ^b   Fox, J G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Endothelial function; Inflammation; Primary glomerulonephritis; Proteinuria

Indexed keywords

ALBUMIN; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LIPID; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CORONARY RISK; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENDOTHELIUM; ENDOTHELIUM LESION; FEMALE; GLOMERULONEPHRITIS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LABORATORY TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR;

EID: 14944343777     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63173     Document Type: Article

References (25)

1. Anderson TJ, Gerhard MD, Meredith IT et al 1995 Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 75: 71B-74B
2. Bolton CH, Downs LG, Victory JG et al 2001 Endothelial dysfunction in chronic renal failure: role of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16: 1189-1197
3. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A 1998 Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79: 399-407
4. Brevetti G, Martone VD, de Cristofaro T et al 2001 High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilatation in patients with peripheral arterial disease. Thromb Haemost 85: 63-66
5. Clausen P, Jensen JS, Jensen G, Feldt-Rasmussen B 2001 Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103: 1869-1874
6. Cockcroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
7. Dogra GK, Herrmann S, Irish AB, Thomas MAB, Watts GF 2002 Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 17: 2220-2225
8. Foley RN, Parfrey PS, Sarnak MJ 1998 Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl 3): 112-119
9. Geering AJH, Newman W 1993 Circulating adhesion molecules in disease. Immunol Today 14: 506-512
10. Grimm RH Jr, Svendsen KH, Kasiske B, Keane WF, Wahi MM 1997 Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 63 (Suppl): 10-14
11. Hernandez E, Toledo T, Alamo C, Mon C, Rodicio JL, Praga M 1997 Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition. Am J Kidney Dis 30: 397-403
12. Jensen JS, Myrup B, Borch-Johnsen K, Jensen G, Jensen T, Feldt-Rasmussen B 1995 Aspects of haemostatic function in healthy subjects with microalbuminuria. A potential atherosclerotic risk factor. Thromb Res 77: 423-430
13. Jensen JS 1995 Renal and systemic transvascular albumin leakage in severe atherosclerosis. Atheroscler Thromb Vasc Biol 15: 1324-1329
14. Jensen JS, Feldt-Rasmussen B, Strangaard S, Schroll M, Borch-Johnsen K 2000 Arterial hypertension, microalbuminuria, and risk of ischaemic heart disease. Hypertension 35: 898-903
15. Levin A 2001 Prevalence of cardiovascular damage in early renal disease. Nephrol Dial Transplant 16 (Suppl 2): 7-11
16. Lind L, Sarabi M, Millgard J, Kahan T, Edner M 1999 Endothelium-dependent vasodilation and structural and functional changes in the cardiovascular system are dependent on age in healthy subjects. Clin Physiol 19: 400-409
17. Lip GYH, Blann A 1997 Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34: 255-265
18. Mogensen CE 1984 Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310: 356-360
19. Paisley KE, Beaman M, Tooke JE, Mohamed-Ali V, Lowe GDO, Shore AC 2003 Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int 63: 624-633
20. Rabb H, Calderon E, Bittle PA, Ramirez G 1996 Alterations in soluble intercellular adhesion-1 and vascular cell adhesion molecule-1 in haemodialysis. Am J Kidney Dis 27: 239-243
21. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD 2003 Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 18: 892-898
22. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B 2002 Mortality, malnutrition and atherosclerosis in ESRD: what is the role of IL-R? Kidney Int Suppl 80: 103-108
23. Stroes ESG, Joles JA, Chong PC, Koomans HA, Rabelink TJ 1995 Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 48: 544-550
24. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townsend JN 2000 Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83: 205-209
25. Whincup PH, Danesh J, Walker M et al 2002 Von Willebrand factor and coronary heart disease: prospective study and metaanalysis. Eur Heart J 23: 1764-1770